Achilleas Gravanis, ex-Professor of Pharmacology, School of Medicine, University of Crete and Researcher, Institute of Molecular Biology & Biotechnology, FORTH. He served as member of the Board of Hellenic Council of Public Health, member of the Biomedical Research Programme Committee, European Commission and the Hellenic Council of Quality Assurance Authority for Higher Education (ADIP). Chairman of the Sectoral Scientific Committee for Biosciences of the Hellenic National Council for Research & Technology (ESET). He also served as a member of the Council of the Hellenic Foundation of Research & Innovation (ELIDEK) in charge of Life Sciences. Affiliated Professor of Pharmacology, School of Pharmacy, Northeastern University, Boston. Affiliated Professor of Pharmacology School of Medicine European University of Cyprus. He served as affiliated Principal Investigator Emulate, a spinoff of WYSS/Harvard. Co-founder and member of the Board of Directors of biotechnology spinoff BioNature, co-founder and CEO of startup  ReNeuroCell Therapeutics. He published 180 papers in journals cited in PubMed (h-index:57).

His research group is developing synthetic neurotrophin receptor agonists, with neuroprotective and neurogenic properties targeting neurodegenerative diseases. Additionally, his group is focusing on 3D microscaffold bioengineering and human neural stem cell technologies to develop neuroimplants for spinal cord injury and brain trauma.